Evidence map›Paper›PMID 34263995›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2021

Optimal blood pressure for patients with end-stage renal disease following coronary interventions.

Ya-Ling Yang, Su-Chan Chen, Cheng-Hsueh Wu, Shao-Sung Huang, Wan Leong Chan, Shing-Jong Lin, Chia-Yu Chou, Jaw-Wen Chen, Pan Ju-Pin, Min-Ji Charng and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Ya-Ling YangDivision of Cardiology, Department of Medicine, Cardinal Tien Hospital, Taiwan, ROC.
Su-Chan ChenDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Cheng-Hsueh WuDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Shao-Sung HuangDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Wan Leong ChanDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Shing-Jong LinDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Chia-Yu ChouDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Jaw-Wen ChenDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Pan Ju-PinDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Min-Ji CharngDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Ying-Hwa ChenDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Tao-Cheng WuDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Tse-Min LuDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Pai-Feng HsuDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Po-Hsun HuangDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Hao-Min ChengDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Chin-Chou HuangDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.ORCID 0000-0002-4217-8734
Shih-Hsien SungDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Yenn-Jiang LinDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.
Hsin-Bang LeuDepartment of Medicine, School of Medicine, National Yang-Ming Chiao University, Taipei, Taiwan, ROC.ORCID 0000-0001-6832-3234
National Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a frequent manifestation of chronic kidney disease but the ideal blood pressure (BP) target in patients with coronary artery disease (CAD) with end-stage renal disease (ESRD) (eGFR < 15 ml/min/1.73m

Indexed as

Coronary Artery DiseaseHypertensionKidney Failure, ChronicPercutaneous Coronary InterventionBlood PressureHumansRisk Factorsblood pressurecoronary artery diseaseend-stage renal diseasepercutaneous coronary intervention

Identifiers

PMID34263995
PMCPMC8678782
OpenAlexW3181032571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.